WallStreetZenWallStreetZen

NASDAQ: INSM
Insmed Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Insmed revenue was $819.56M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $306.0M, up 16% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INSM annual revenue was $606.4M, with 66.7% growth year-over-year.

INSM past revenue growth

How has INSM's revenue growth performed historically?

Company
115.09%
Industry
260.73%
Market
38.24%
INSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INSM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INSM revenue history

Current Revenue
$819.6M
Current Earnings
-$1.2B
Current Profit Margin
-144.4%

Be the first to know when INSM announces revenue.

INSM Revenue History By Year

INSM Yearly RevenueINSM RevenueINSM ChangeINSM Revenue Growth
2025-12-31$606.42M$242.72M+66.73%
2024-12-31$363.71M$58.50M+19.17%
2023-12-31$305.21M$59.85M+24.39%
2022-12-31$245.36M$56.90M+30.19%
2021-12-31$188.46M$24.05M+14.63%
2020-12-31$164.41M$27.95M+20.48%
2019-12-31$136.47M$126.63M+1,287.56%
2018-12-31$9.84MN/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00-$11.50M-100.00%
2013-12-31$11.50MN/AN/A
2012-12-31$0.00-$4.42M-100.00%
2011-12-31$4.42M-$2.50M-36.18%
2010-12-31$6.92M-$3.45M-33.28%
2009-12-31$10.37M-$1.33M-11.33%
2008-12-31$11.70M$4.12M+54.32%
2007-12-31$7.58M$6.56M+639.61%
2006-12-31$1.03M$894.00k+682.44%
2005-12-31$131.00k-$6.00k-4.38%
2004-12-31$137.00k-$13.00k-8.67%
2003-12-31$150.00k-$1.81M-92.33%
2002-12-31$1.96M$1.66M+560.47%
2001-12-31$296.00k$236.00k+393.33%
2000-12-31$60.00kN/AN/A
1999-12-31$0.00N/AN/A
1998-12-31$0.00N/AN/A

1 of 2

Insmed Revenue FAQ

What was INSM's revenue last quarter?

On Invalid Date, Insmed (NASDAQ: INSM) reported Q1 2026 revenue of $305.96 million up 229.62% year over year. In the same quarter last year, Insmed's revenue was $92.82 million.

What was Insmed's revenue in 2025?

Insmed's annual revenue for the twelve months ending Dec 31, 2025 was $606.42 million, a 66.73% increase year over year.

How much does Insmed make in a day?

Based on Insmed annual revenue for the past five years, INSM makes an average of $936,524.38 per day.

What was Insmed's annual revenue growth in the past year?

As of Q2 2026, Insmed's revenue has grown 115.09% year over year. This is 145.64 percentage points lower than the US Biotechnology industry revenue growth rate of 260.73%. Insmed's revenue in the past year totaled $819.56 million.

How much does Insmed make in a year?

Insmed's revenue by year for the past five years is:
  • Insmed's revenue for the twelve months ending Dec 31, 2025 was $606.42 million, a 66.73% increase year over year.
  • Insmed's annual revenue for Dec 31, 2024 was $363.71 million, a 19.17% increase from 2023.
  • Insmed's annual revenue for 2023 was $305.21 million, a 24.39% increase from 2022.
  • Insmed's annual revenue for 2022 was $245.36 million, a 30.19% increase from 2021.
  • Insmed's annual revenue for 2021 was $188.46 million, a 14.63% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.